Advertisement

Analytical and Bioanalytical Chemistry

, Volume 378, Issue 5, pp 1351–1356 | Cite as

Voltammetric behaviour and determination of moxifloxacin in pharmaceutical products and human plasma

Original Paper

Abstract

The oxidative behaviour of moxifloxacin was studied at a glassy carbon electrode in different buffer systems using cyclic, differential pulse, and Osteryoung square-wave voltammetry. The oxidation process was shown to be irreversible over the entire pH range studied (2.0–10.0) and was diffusion-controlled. The methods were performed in Britton–Robinson buffer and the corresponding calibration graphs were constructed and statistical data were evaluated. When the proposed methods were applied at pH 6.0 linearity was achieved from 4.4×10−7 to 1.0×10−5 mol L−1. Applicability to tablets and human plasma analysis was illustrated. Furthermore, a high-performance liquid chromatographic method with diode-array detection was developed. A calibration graph was established from 4.0×10−6 to 5.0×10−5 mol L−1 moxifloxacin. The described methods were successfully employed with high precision and accuracy for estimation of the total drug content of human plasma and for pharmaceutical dosage forms of moxifloxacin.

Keywords

Moxifloxacin Cyclic voltammetry Differential pulse voltammetry Osteryoung square-wave voltammetry High-performance liquid chromatography Human plasma 

References

  1. 1.
    Woodcock JM, Andrews JM, Broswell FJ, Brenwald NP, Wise R (1997) Antimicrob Agents Chemother 41:101–106PubMedGoogle Scholar
  2. 2.
    Fass RJ (1997) Antimicrob Agents Chemother 41:1818–1824PubMedGoogle Scholar
  3. 3.
    Roblin PM, Hammerschlag MR (1998) Antimicrob Agents Chemother 42:951–952PubMedGoogle Scholar
  4. 4.
    Donati M, Rodriguez FM, Olmo A, D’Apote L, Ceveni R (1999) Antimicrob Agents Chemother 43:825–827CrossRefGoogle Scholar
  5. 5.
    Biedenbach DL, Barrett MS, Croco MAT, Jones RN (1998) Diagn Microbiol Infect Dis 32:45–50CrossRefPubMedGoogle Scholar
  6. 6.
    Stass H, Dalhoff A (1997) J Chromatogr 702:163–174CrossRefGoogle Scholar
  7. 7.
    Lemoine T, Breilh D, Ducint D, Dubrez J, Jougon J, Velly JF, Saux MC (2000) J Chromatogr B 742:247–254CrossRefGoogle Scholar
  8. 8.
    Ba BB, Etienne R, Ducint D, Quentin C, Saux MC (2001) J Chromatogr B 754:107–112CrossRefGoogle Scholar
  9. 9.
    Vishwanathan K, Bartlett MG, Stewart JT (2002) J Pharm Biomed Anal 30:961–968CrossRefPubMedGoogle Scholar
  10. 10.
    Liang H, Kays MB, Sowinski KM (2002) J Chromatogr B 772:53–63Google Scholar
  11. 11.
    Ocana JA, Barragan FJ, Callejon M (2000) Analyst 125:2322–2325CrossRefPubMedGoogle Scholar
  12. 12.
    Biryol İ, Erk N (2003) Anal Lett 36:2699–2711CrossRefGoogle Scholar
  13. 13.
    Erk N (2003) Die Pharmazie 58:870–873PubMedGoogle Scholar
  14. 14.
    Erk N, Biryol İ (2003) Die Pharmazie 58:699–704PubMedGoogle Scholar
  15. 15.
    Nigovic B, Simunic B (2003) J Pharm Biomed Anal 31:169–174CrossRefPubMedGoogle Scholar
  16. 16.
    Vilchez JL, Taoufiki J, Araujo L, Navalon A (2003) J Pharm Biomed Anal 31:465–471CrossRefPubMedGoogle Scholar
  17. 17.
    Ghoneim MM, Mabrouk MM, Tawfik A (2002) J Pharm Biomed Anal 31:1–8Google Scholar
  18. 18.
    Radi A, El-Sherif Z (2002) Talanta 58:319–324CrossRefGoogle Scholar
  19. 19.
    Gosser DK (1993) In: Cyclic voltammetry simulation and analysis of reaction mechanisms. VCH, New York, p 43Google Scholar
  20. 20.
    Bard A, Faulkner LR (2001) Electrochemical methods: fundamentals and applications, 2nd edn. Wiley, New York, p 236Google Scholar
  21. 21.
    International Conference on Harmonisation, Notes for Guidance,http://www.fda.gov/cder/guidance

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  1. 1.Department of Analytical Chemistry, Faculty of PharmacyAnkara UniversityAnkaraTurkey

Personalised recommendations